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ANKYLOSING SPONDYLITIS 
 
A SUMMARY AND REVIEW 
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Index Terms:  Ankylosing spondylitis (AS), Marie-
Strumpell spondylitis, Von Bechterew's disease, 
chiropractic. 
 
Summary:  Ankylosing spondylitis is a relatively rare 
disease affecting 0.1% to 0.2% of the white population 
(1)(2). 
 
It is a disease characterised by inflammatory stiffening 
of the spine, affecting in particular the cartilaginous 
joints of the spine and the sacro-iliac joints.  In the 
advanced form there is o ssification of ligaments and 
spinal fusion with a characteristic stooped posture (3). 
 
Ankylosing spondylitis occurs most commonly in white 
men in their twenties with the male:female ratio at 3:1 
(2).  There is a strong familial occurrence (8), and it is 
less common in American Negroes (4). 
 
Ankylosing spondylitis is not a form of rheumatoid 
arthritis, although they do have similarities.  
Ankylosing spondylitis exists as a spectrum of clinical 
presentations both axial and appendicular (3). 
 
Ankylosing spondylitis shares many of its features with 
other related seronegative (for rheumatoid factor) 
spondyloarthopathies, such as Reiter's Syndrome, 
psoriatic arthritis, reactive arthritis, enteropathic 
arthropaties (associated with ulcerative colitis, Crohn's 
disease and Whipple's disease) and juvenile chronic 
arthritis (5). 
 
Approximately 90% of patients with ankylosing 
spondylitis have an association with the HLA antigen 
with B27 specificity, whereas only 6%  - 8% of the 
population have the gene (6). 
 
According to Ebringer (7) ankylosing spondylitis is 
probably produced by repeated episodes of Klebsiella-
reactive arthritis, usually in HLA-B27 positive 
individuals.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
He suggests a pathogenetic pathway commencing with 
gut wall infection produced by Klebsiella.  Followed by 
antibody production against Klebsiella produced by 
local lymph nodes, related to the gut, sacro-iliac joints 
and the lumbar spine. 
 
Then inflammation is  produced because anti-Klebsiella 
antibodies bind to HLA-B27 positive cells in the spine, 
entheses (ligament and tendon attachments to bone) 
and lymph nodes thereby activating the so called 
"complement cascade". 
 
This is followed by Klebsiella reactive arthritis which is 
produced by reoccurent waves of infection due to 
commensal Klebsiella, probably evoked by a high 
starch diet. 
 
Finally, ankylosing spondylitis appears to be the end 
stage of repeated Klebsiella-reactive arthritis, occurring 
almost exclusively in HLA-B27 positive individuals (7). 
 
The clinical picture of ankylosing spondylitis 
commonly presents as dull pain of insidious onset in 
the sacro-iliac region, lumbar region, greater trochanter 
region or even down the proximal part of the posterior 
thigh.  Pain is usually aggravated by sudden 
movements and coughing and sneezing. 
 
As the condition worsens back pain and stiffness occur 
at rest particularly in the morning.  T his may last 
several hours and is often relieved by heat and exercise 
(2.3,6,8). 
 
Enthesitis causing extra-articular bony tenderness can 
be a common complaint particularly at the costo-sternal 
junctions, spinous processes, iliac crests, greater 
trochanters, ischial tubercles or heels (8). 
 
Hip and shoulder joints are involved in one third of 
patients.  Hip involvement as the presenting 
manifestation is more common in childhood or 
adolescence (9).  Involvement of the peripheral joints is 
relatively infrequent (8). 
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About 25% of all patients with ankylosing spondylitis 
develop at least one episode of acute iritis (3).  
Cardiovascular complications such as aortitis, aortic 
valve incompetence, pericarditis and cardiomegaly can 
occur but are rare.  Pulmonary function remains normal 
generally due to an increased diaphragmatic 
contribution (3,6,8). 
 
As ankylosing spondylitis progresses the patient 
becomes stooped into flexion and with cervical 
involvement the head is held in an anterior position 
and neck m ovements are restricted.  Finally, bony 
ankylosis of the entire spine can occur resulting in 
profound stiffness and the so-called "bamboo spine" 
appearance as seen on radiographs (1,3,10). 
 
Trauma to the ankylosing spondylitis patient may result 
in serious fractures and can result in severe 
neurological deficits (12).  The fractures can occur even 
with minimal trauma and are due to spinal immobility 
and osteoporosis (12,13). 
 
Differential Diagnosis:  A differential diagnosis list 
includes rheumatoid arthritis, diffuse idiopathic skeletal 
hyperostosis (DISH), psoriatic arthritis, Reiter's 
syndrome, enteropathic arthritides, reactive arthritis, 
septic sacro-iliitis, Scheuermann's disease, congenital 
kyphoscoliosis, osteitis condensans ilii, 
hyperparathyroidism, osteoarthritis, gouty arthritis and 
infection (1,2,3,5,6,8,11). 
 
Usual and Customary Examination Procedures:  
 
1.  Physical examination:  This reveals loss of 
mobility of the lumbar spine.  Note here that 
flexion may not be a reliable guide to a decreased 
lumbar range of motion due to hip movements (8). 
 
  A decrease in chest expansion and a stooped 
kyphotic posture as the disease progresses are tell-
tale signs(2,8).  There is often tenderness over one 
or both sacro-iliac joints and the entheses (2). 
 
2.  Diagnostic Imaging:  Plain radiographs are the 
imaging modality of choice although bone scans 
may be "hot" in affected joints when the disease is 
active (18). 
 
  (a)  Sacro-iliac joint involvement commences with 
pseudo-widening of joint spaces, then erosive and 
sclerotic changes particularly on the iliac side, and 
finally ankylosis of the joints which narrow and 
obliterate.  Sclerosis dissipates and is replaced by 
generalised osteoporosis (14). 
 
  (b)  Spine: Syndesmophyte formation, which 
represents ligamentous ossification are the spinal 
hallmarks of ankylosing  spondylitis, often 
commencing at the thoraco-lumbar junction but 
affecting eventually the entire spine to give the 
"Bamboo-spine" appearance (2,8,14). 
 
  The apophyseal joints fuse, there is a loss of the 
lumbar lordosis and an increase in the thoracic 
kyphosis, eventually the spine becomes 
osteoporotic (2,3,4,8,13,14). 
 
  (c)  Peripheral Joints:  Initially, the x -ray 
appearance of proximal joints in ankylosing 
spondylitis may resemble rheumatoid arthritis.  
However, there is a greater tendency in ankylosing 
spondylitis to central articular erosion's and 
proliferative new bone formation at the margins 
and whiskery spicules occur due to enthesitis in the 
pelvis at the sacrotuberious and sacrospinal 
ligament insertions, the greater trochanter of the 
femur, plantar fascia and achilles tendon (6). 
 
3.  Laboratory Tests: 
 
  (a)  ESR/CRP is raised in up to 75% of patients 
but it is not a reliable indicator of disease activity 
(6,8). 
 
  (b)  Mild normocytic, normochromic anaemia may 
be present in 15% of patients (8). 
 
  (c)  HLA-B27 is positive in over 90% of 
ankylosing spondylitis patients (2). 
 
  (d)  A positive rheumatoid factor is notably absent 
(4). 
 
GOALS OF TREATMENT: 
 
1.  Control pain and inflammation. 
2.  Maintain  maximum skeletal mobility. 
3.  Prevent deformities. 
4.  Maintain or enhance aerobic fitness, muscular 
strength and endurance. 
5.  Educate patients and family about the disease. 
 
CHIROPRACTIC MANAGEMENT: 
 
1.  Analgesic and anti-inflammatory physical therapy 
modalities can be used for exacerbations. 
 
2.  An active exercise programme is the cornerstone of 
management (15).  Rest should only be prescribed 
during acute exacerbations.  Exercises should be 
aimed at spinal ranges o f motion particularly 
extension.  Swimming is ideal in this regard and it 
also is performed without weight bearing and 
enhances aerobic capacity. ANKYLOSING SPONDYLITIS 
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  Cycling and jogging are to be condoned only with 
reservation, cycling because of the flexed posture 
and jogging because of the jarring effect. 
  Breathing and chest expansion exercises are also 
important (2.3.4.5.6). 
  Heat applied before and cold applied after exercises 
may be useful (3). 
 
3.  The use of mobilisation and manipulation in 
ankylosing spondylitis  is yet to be studied.  
However, two factors should be borne in mind: 
 
  (a)  Ankylosing spondylitis patients like any other 
patient may develop mechanical spinal dysfunction 
which may respond to mechanical treatment. 
 
  (b)  The main contraindications to mechanical 
treatment are: ankylosing spondylitis in the 
actively inflamed stage where treatment might 
exacerbate an already inflamed area, joint 
immobility or fusion and any attendant 
osteoporosis where vigorous treatment could cause 
bony damage particularly fracture and atlanto-axial 
instability from the disease process itself where 
treatment might conceivably result in disastrous 
sequelae. 
 
  Certainly, gentle techniques in the quiescent phase 
of early ankylosing spondylitis would not seem to 
be contraindicated where a manipulable lesion 
exists. 
 
4.  Periodic review is important to gauge the 
progression of the disease.  In this regard clinical 
and  x-ray tests are used.  Clinical indicators 
include measuring pain and inflammation:  pain 
can be assessed using a visual analogue scale while 
inflammation can be gauged by the duration of 
morning stiffness (eg. 2 hours) (16). 
 
  Mobility of the spinal column should be measured 
checking lateral flexions, extension and 
  rotations.  Flexion should be measured using 
the Schober  method (8).  Chest expansion should 
also be measure suing reproducible methods (8). 
 
  Two other indices of disease progression are the 
enthesopathy index proposed by Mander et al (16) 
and the articular and functional indices proposed 
by Dougados et al (17). 
 
  Serial radiographs are useful to monitor the disease 
progression but may not correlate to any favourable 
effect of treatment (8). 
 
5.  Anti-inflammatory drugs are the most useful 
medical therapy.  They suppress the pain and 
stiffness and facilitate exercise programmes (3). 
However, drug therapy does not alter the 
progression of the disease (6).  The aim of 
prescription is to find the smallest dose necessary 
for repeated symptomatic relief (5). 
 
6.  Counselling and education for patients and family 
regarding ankylosing spondylitis should be an 
integral part of management (3.15). 
 
PROGNOSIS: 
 
Although not curable, ankylosing spondylitis is one of 
the most rehabilitable of all the chronic rheumatic 
diseases (3).  Less then 10% develop relentlessly 
crippling disease.  Most longitudinal studies of 
ankylosing spondylitis survival curves approximate that 
of the general population (6).  Death if it occurs is 
usually attributable to cardiac involvement, cervical 
spine fractures or rarely secondary amyloidosis (2). 
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